The good news is that a new initiative called ADDI is pooling research data to accelerate curing Alzheimer’s. Watch Bill Gates on the Alzheimer’s Disease Data Initiative.
CUTTING-EDGE VIDEO + ARTICLE: See Dr. Anthony Fitzpatrick use world-class cryo-electron microscopes to reveal molecular secrets leading to a cure for Alzheimer’s.
A Different Kind of Alzheimer’s Drug Just Delivered One of the Most Interesting Results in Years
Could Leqembi be given faster and more easily in the future? The new Biogen–Alteogen deal suggests it’s possible—but it doesn’t confirm changes to Leqembi. Here’s what professionals and families should understand.
Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.
Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.
New research hints at a simple, widely available vaccine that may help protect brain health.
A twice-daily pill called ALZ-801 brings new hope to high-genetic-risk Alzheimer’s. Early findings suggest meaningful slowing of decline, stronger safety, and brain structure protection.
NEW RESEARCH: A diabetes medication already helping millions, called Jardiance, improves memory, strengthens blood flow, and supports overall brain health in pre- and early Alzheimer’s.
Bill Gates says, “I am blown away by how much we have learned about Alzheimer’s disease over the last couple years.” See his compelling video and insight-filled blog post.
Twenty percent of people over 65 have mild memory and thinking problems that don’t interfere with day-to-day life. Doctors call this MCI, short for Mild Cognitive Impairment. Find out more about what it is and what to do about it.
FREE DOWNLOAD: This booklet is rich with care practices based on research by highly-credentialed investigators.
ALZHEIMER’S & ART – VIDEO: Art helps people with Alzheimer’s enjoy the moment. The “Contemporary Journeys” program shows, it’s a life that can still offer both great joy and meaningful experiences – through the power of art. Kate McDonald of Twin Cities PBS in Minneapolis reports.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
